Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Environmental Research|June 22, 2023
Application of curcumin nanoformulations to target folic acid receptor in cancer: Recent trends and advancesArif Hussain, Ajay Kumar, Vivek Uttam, et al.
Nucleic Acids Research|March 31, 2006
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapyVeronica Albertini, Aklank Jain, Sara Vignati, et al.
Oncology Research|March 20, 2025
The regulatory role of ZFAS1/miRNAs/mRNAs axis in cancer: a systematic reviewRahul Kumar Singh, Surojit Mandal, Adrija Mohanta, et al.
Translational Oncology|December 6, 2022
Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfectionHardeep Singh Tuli, Vivek Kumar Garg, Sakshi Bhushan, et al.
Cancer Treatment and Research Communications|June 25, 2022
miR-590-5p: A double-edged sword in the oncogenesis processTushar Singh Barwal, Neha Singh, Uttam Sharma, et al.
Seminars in Cancer Biology|May 29, 2020
Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancementVaishali Aggarwal, Hardeep Singh Tuli, Mousumi Tania, et al.
Toxicology Reports|December 23, 2022
Ampelopsin targets in cellular processes of cancer: Recent trends and advancesHardeep Singh Tuli, Katrin Sak, Vivek Kumar Garg, et al.
Seminars in Cancer Biology|November 1, 2020
Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significanceHardeep Singh Tuli, Sonam Mittal, Diwakar Aggarwal, et al.
Plos Genetics|October 3, 2013
Guanine holes are prominent targets for mutation in cancer and inherited diseaseAlbino Bacolla, Nuri A Temiz, Ming Yi, et al.
Cell Death Discovery|September 29, 2024
The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancerRitu Yadav, Rinku Khatkar, Kenneth C-H Yap, et al.
Pageof 8